AZR
Adial Pharmaceuticals, Inc.
There isn't enough reported data to score AZR yet.
AZR Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
AZR's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
AZR PE Valuation
AZR has no meaningful PE right now: it lost money over the past year.
AZR Forward outlook
There aren't enough analyst estimates for AZR to show an outlook.
AZR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$23.87 | +$95.87 |
| Q2 2025 | -$31.37 | +$108.37 |
| Q1 2025 | -$41.62 | +$59.37 |
| Q4 2024 | -$87.87 | +$27.12 |
| Q3 2024 | -$119.74 | +$21.86 |
| Q2 2024 | -$139.74 | +$47.36 |
| Q1 2024 | -$100.99 | +$210.11 |
| Q4 2023 | -$114.99 | +$203.76 |
AZR is still losing money, but far less than before: $23.87 per share over the past year, against $650.00 at its worst in mid-2021.
AZR Quarterly Revenue
AZR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.6M | -$4.8M |
| Q2 2026 | -$6.4M | -$4.6M |
| Q1 2026 | -$1.6M | -$27K |
| Q4 2025 | -$1.3M | +$129.3K |
| Q3 2025 | -$1.8M | -$139.3K |
| Q2 2025 | -$1.7M | +$398.9K |
| Q1 2025 | -$1.6M | +$40.8K |
| Q4 2024 | -$1.5M | -$231.3K |
AZR has burned cash in almost every quarter: −$16M over the past year, against −$7M the year before.
AZR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +209% | +9.7M shares |
| 1 year | +3265% | +13.9M shares |
| 3 years | +35587% | +14.3M shares |
| 5 years | +79029% | +14.3M shares |
AZR has 14M diluted shares, up 3265% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
AZR Net Leverage
AZR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AZR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.9 | Neutral |
| Stochastic | 21.8 | Neutral |
AZR's weekly RSI is 48 (neutral) and its Stochastic is 22 (neutral).
AZR PE vs Healthcare Sector
AZR has no meaningful PE right now: it lost money over the past year.
AZR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.90 | 4.1% below |
| 20 week MA | $4.12 | 9.2% below |
| 50 week MA | $3.65 | 2.5% above |
| 100 week MA | $8.98 | 58% below |
| 200 week MA | $48.5 | 92% below |
AZR's trend is mixed: it's above one of its five weekly moving averages, and 92% below its 200-week average.
AZR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1,531.3 | $1,125.0 | -27% |
| 2021 | $1,125.0 | $1,737.5 | +54% |
| 2022 | $1,737.5 | $137.5 | -92% |
| 2023 | $137.5 | $46.5 | -66% |
| 2024 | $46.5 | $25.5 | -45% |
| 2025 | $25.5 | $5.75 | -77% |
| 2026 YTD | $5.75 | $3.74 | -35% |
AZR has finished four years in a row lower, and it's down 35% so far in 2026.